WBI Investments LLC Has $845,000 Stock Position in UnitedHealth Group Incorporated $UNH

WBI Investments LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 348.5% during the second quarter, Holdings Channel reports. The institutional investor owned 2,709 shares of the healthcare conglomerate’s stock after purchasing an additional 2,105 shares during the period. WBI Investments LLC’s holdings in UnitedHealth Group were worth $845,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the business. Brighton Jones LLC boosted its position in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after buying an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC boosted its holdings in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after acquiring an additional 2,324 shares during the last quarter. Crestwood Advisors Group LLC raised its holdings in shares of UnitedHealth Group by 29.2% in the first quarter. Crestwood Advisors Group LLC now owns 5,357 shares of the healthcare conglomerate’s stock valued at $2,806,000 after purchasing an additional 1,210 shares during the last quarter. PFG Advisors boosted its holdings in UnitedHealth Group by 19.9% during the first quarter. PFG Advisors now owns 11,322 shares of the healthcare conglomerate’s stock worth $5,930,000 after purchasing an additional 1,876 shares during the last quarter. Finally, Hartford Funds Management Co LLC lifted its position in shares of UnitedHealth Group by 13.8% during the 1st quarter. Hartford Funds Management Co LLC now owns 5,939 shares of the healthcare conglomerate’s stock worth $3,110,000 after buying an additional 722 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently commented on UNH. Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. JPMorgan Chase & Co. increased their price target on shares of UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research report on Thursday, October 9th. Weiss Ratings upgraded shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, October 24th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 price target on shares of UnitedHealth Group in a report on Tuesday, August 26th. Finally, Piper Sandler decreased their target price on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research report on Tuesday, October 28th. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $313.77 on Wednesday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $622.83. The business’s fifty day moving average is $346.96 and its 200 day moving average is $317.63. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The firm has a market cap of $284.22 billion, a price-to-earnings ratio of 16.38, a PEG ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. During the same period in the prior year, the business posted $7.15 earnings per share. The company’s revenue was up 12.2% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a dividend yield of 2.8%. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.